🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark W. Richards

AstraZeneca (United Kingdom)

ORCID: 0000-0003-1108-2825

Also affiliated with University of Leeds, University of Leicester, Institute of Structural and Molecular Biology

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma.

71 citations

Tong Liang, Yann Jamin, Susanne Walz, Colin Kwok, Anne Hakkert +38 more